Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
NF-κB in defense and diseaseNF-κB comprises a family of inducible transcription factors that serve as important regulators of the host immune and inflammatory response.In addition, NF-κB is also involved in protecting cells from undergoing apoptosis in response to DNA damage or cytokine treatment.Stimulation of the NF-κB pathway is mediated by diverse signal transduction cascades.These signals activate the IκB kinases, IKKα and IKKβ, which phosphorylate inhibitory proteins known as IκB to result in their ubiquitination and degradation by the proteasome.The degradation of IκB results in the translocation of NF-κB from the cytoplasm to the nucleus where it activates the expression of specific cellular genes.As we better understand the regulation of the NF-κB pathway, the potential for inhibiting this pathway has received attention.Agents that inhibit this pathway, such as glucocorticoids and aspirin, can reduce the inflammatory response, while other agents such as dominant negative IκB proteins potentiate the effects of chemotherapy and radiation therapy in the treatment of cancer.Here, we discuss cellular genes and disease states associated with activation of the NF-κB pathway and consider therapeutic strategies to prevent the prolonged activation of the NF-κB pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727 · cited 4×
“proteins involved in antigen presentation, and receptors required for neutrophil adhesion and migration (2).”
BackgroundInfluentialThe peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525 · cited 2×
“Two roles of cyPGs in regulation of the NF-κB pathway have been proposed (42, 43).”
BackgroundActivators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Cited by
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
Kurutas, E. B. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0186-5 · Cited by 2,152
Dietary phenolics: chemistry, bioavailability and effects on health
Crozier, A., Jaganath, I. B., & Clifford, M. N. (2009) · Natural Product Reports · doi:10.1039/b802662a · Cited by 1,988
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
Hoffmann, A., Levchenko, A., Scott, M. L., & Baltimore, D. (2002) · Science · doi:10.1126/science.1071914 · Cited by 1,858
Mechanisms of photoaging and chronological skin aging
Fisher, G. J., Kang, S., Varani, J., Bata-Csorgo, Z., Wan, Y., Datta, S., & Voorhees, J. J. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.11.1462 · Cited by 1,849
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Itzkowitz, S. H., & Yio, X. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2004 · Cited by 1,274
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Leeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 943
Nuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Medium- and Large-Vessel Vasculitis
Weyand, C. M., & Goronzy, J. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022694 · Cited by 788
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
Grzanna, R., Lindmark, L., & Frondoza, C. G. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.125 · Cited by 778
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 749
Chang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402945 · Cited by 725
Anti-Inflammatory Action and Mechanisms of Resveratrol
Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., & He, J. (2021) · Molecules · doi:10.3390/molecules26010229 · Cited by 698
NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis
Roman-Blas, J. A., & Jimenez, S. A. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.04.008 · Cited by 688
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
IκB kinases: key regulators of the NF-κB pathway
Yamamoto, Y., & Gaynor, R. B. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.003 · Cited by 640
Self-citationKunnumakkara, A. B., Guha, S., Krishnan, S., Diagaradjane, P., Gelovani, J., & Aggarwal, B. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4257 · Cited by 578
NF-κB as a therapeutic target in cancer
Orlowski, R. Z., & Baldwin, A. S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02375-4 · Cited by 553
NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535
Influence of Resveratrol on the Immune Response
Malaguarnera, L. (2019) · Nutrients · doi:10.3390/nu11050946 · Cited by 526
NF-κB, chemokine gene transcription and tumour growth
Richmond, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri887 · Cited by 523
Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity
Werner, S. L., Barken, D., & Hoffmann, A. (2005) · Science · doi:10.1126/science.1113319 · Cited by 505
Moynagh, P. N. (2005) · Journal of Cell Science · doi:10.1242/jcs.02579 · Cited by 489
Therapeutic applications of compounds in the Magnolia family
Lee, Y.-J., Lee, Y. M., Lee, C.-K., Jung, J. K., Han, S. B., & Hong, J. T. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.010 · Cited by 481
Lin, Y. G., Kunnumakkara, A. B., Nair, A., Merritt, W. M., Han, L. Y., Armaiz-Pena, G. N., Kamat, A. A., Spannuth, W. A., Gershenson, D. M., Lutgendorf, S. K., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3072 · Cited by 440
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Hassa, P. O., & Hottiger, M. O. (2002) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-002-8527-2 · Cited by 427
Cyclooxygenase isozymes and their gene structures and expression
Tanabe, T., & Tohnai, N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00024-2 · Cited by 422
Curcumin for chemoprevention of colon cancer
Johnson, J. J., & Mukhtar, H. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.005 · Cited by 396
NF-κB and IKK as therapeutic targets in cancer
Kim, H. J., Hawke, N., & Baldwin, A. S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401877 · Cited by 391
Cyclooxygenases in cancer: progress and perspective
Zha, S., Yegnasubramanian, V., Nelson, W. G., Isaacs, W. B., & De Marzo, A. M. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.014 · Cited by 389
Xia, Y.-F., Ye, B.-Q., Li, Y.-D., Wang, J.-G., He, X.-J., Lin, X., Yao, X., Ma, D., Slungaard, A., Hebbel, R. P., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4207 · Cited by 378
AGGARWAL, B. B., & SHISHODIA, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.054 · Cited by 357
Inflammation and the development of pancreatic cancer
Farrow, B., & Evers, B. M. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(02)00015-4 · Cited by 338
“NF-kB activates cyclin D1 expression, a regulatory protein that promotes cell cycle activity [91], and cyclin D1 is upregulated in several pancreatic cancer cell lines [92].”
BackgroundRadiation-Induced Endothelial Vascular Injury
Venkatesulu, B. P., Mahadevan, L. S., Aliru, M. L., Yang, X., Bodd, M. H., Singh, P. K., Yusuf, S. W., Abe, J.-I., & Krishnan, S. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2018.01.014 · Cited by 334
Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2
Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S., Nguyen, D. U., Pham, C. G., Nelsbach, A. H., Melis, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1093 · Cited by 321
Kang, J., Tsuyoshi, G., Han, I., Kawada, T., Kim, Y. M., & Yu, R. (2010) · Obesity · doi:10.1038/oby.2009.301 · Cited by 313
Natural products as targeted modulators of the nuclear factor-κ B pathway
Bremner, P., & Heinrich, M. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778637 · Cited by 312
Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
Strehl, C., Ehlers, L., Gaber, T., & Buttgereit, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01744 · Cited by 308
Kaileh, M., Vanden Berghe, W., Heyerick, A., Horion, J., Piette, J., Libert, C., De Keukeleire, D., Essawi, T., & Haegeman, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606728200 · Cited by 301
Jayakumar, T., Hsieh, C.-Y., Lee, J.-J., & Sheu, J.-R. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/846740 · Cited by 301
Immunological Approaches Towards Cancer and Inflammation: A Cross Talk
Qu, X., Tang, Y., & Hua, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00563 · Cited by 301
Signaling Molecules of the NF-κB Pathway Shuttle Constitutively between Cytoplasm and Nucleus
Birbach, A., Gold, P., Binder, B. R., Hofer, E., de Martin, R., & Schmid, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112475200 · Cited by 299
A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms
Lee, B.-N., Dantzer, R., Langley, K. E., Bennett, G. J., Dougherty, P. M., Dunn, A. J., Meyers, C. A., Miller, A. H., Payne, R., Reuben, J. M., et al. (2004) · Neuroimmunomodulation · doi:10.1159/000079408 · Cited by 294
Natural anti-inflammatory agents for pain relief
Bost, J., Maroon, A., & Maroon, J. (2010) · Surgical Neurology International · doi:10.4103/2152-7806.73804 · Cited by 292
Portrait of inflammatory response to ionizing radiation treatment
Di Maggio, F. M., Minafra, L., Forte, G. I., Cammarata, F. P., Lio, D., Messa, C., Gilardi, M. C., & Bravatà, V. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0058-3 · Cited by 286
Aggarwal, B. B., Ichikawa, H., Garodia, P., Weerasinghe, P., Sethi, G., Bhatt, I. D., Pandey, M. K., Shishodia, S., & Nair, M. G. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.87 · Cited by 286
Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level
Gunaydin, C., & Bilge, S. S. (2019) · The Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2018.0010 · Cited by 284
Nanji, A. A., Jokelainen, K., Tipoe, G. L., Rahemtulla, A., Thomas, P., & Dannenberg, A. J. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00230.2002 · Cited by 283
Direct tumor damage mechanisms of photodynamic therapy.
Nowis, D., Makowski, M., Stokłosa, T., Legat, M., Issat, T., & Gołab, J. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3447 · Cited by 282
Vitamin C Suppresses TNFα-Induced NFκB Activation by Inhibiting IκBα Phosphorylation
Cárcamo, J. M., Pedraza, A., Bórquez-Ojeda, O., & Golde, D. W. (2002) · Biochemistry · doi:10.1021/bi0263210 · Cited by 280
Neuroinflammation in Alzheimer’s disease
Zhang, F., & Jiang, L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75546 · Cited by 276
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Shen, H.-M., & Tergaonkar, V. (2009) · Apoptosis · doi:10.1007/s10495-009-0315-0 · Cited by 275
Desai, S. J., Prickril, B., & Rasooly, A. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1446091 · Cited by 274
Kim, J.-H., Na, H.-J., Kim, C.-K., Kim, J.-Y., Ha, K.-S., Lee, H., Chung, H.-T., Kwon, H. J., Kwon, Y.-G., & Kim, Y.-M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.019 · Cited by 273
Mitochondria and Reactive Oxygen Species: Physiology and Pathophysiology
Bolisetty, S., & Jaimes, E. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14036306 · Cited by 273
Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy
Amano, T., Yamasaki, S., Yagishita, N., Tsuchimochi, K., Shin, H., Kawahara, K.-I., Aratani, S., Fujita, H., Zhang, L., Ikeda, R., et al. (2003) · Genes & Development · doi:10.1101/gad.1096603 · Cited by 270
Molecular mechanisms of interleukin-10-mediated inhibition of NF-κ B activity: a role for p50
DRIESSLER, F., VENSTROM, K., SABAT, R., ASADULLAH, K., & SCHOTTELIUS, A. J. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02342.x · Cited by 269
Gupta, S., Afaq, F., & Mukhtar, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5672 · Cited by 269
Gomes, M. B., & Negrato, C. A. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-80 · Cited by 269
Jeong, W.-S., Kim, I.-W., Hu, R., & Kong, A.-N. T. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022413.43212.cf · Cited by 264
IκB kinase β (IKKβ/IKK2/IKBKB)—A key molecule in signaling to the transcription factor NF-κB
Schmid, J. A., & Birbach, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.006 · Cited by 262
IL-6 Induces NF-κB Activation in the Intestinal Epithelia
Wang, L., Walia, B., Evans, J., Gewirtz, A. T., Merlin, D., & Sitaraman, S. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3194 · Cited by 243
“Additionally, many therapies for IBD act at least in part through the inhibition of NF- B or through inhibition of signals that activate NF- B (22).”
BackgroundTumor-related interleukins: old validated targets for new anti-cancer drug development
Setrerrahmane, S., & Xu, H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0721-9 · Cited by 237
“nuclear genes especially via the NFκB and subsequent induction of inflammatory response [74] (Fig.”
Balloy, V., Huerre, M., Latgé, J.-P., & Chignard, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.494-503.2005 · Cited by 231
Targeting Inflammatory Pathways by Flavonoids for Prevention and Treatment of Cancer
Prasad, S., Phromnoi, K., Yadav, V., Chaturvedi, M., & Aggarwal, B. (2010) · Planta Medica · doi:10.1055/s-0030-1250111 · Cited by 229
Ren, Y., Geng, Y., Du, Y., Li, W., Lu, Z.-M., Xu, H.-Y., Xu, G.-H., Shi, J.-S., & Xu, Z.-H. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.005 · Cited by 204
Abdel-Latif, M. M. M., O'Riordan, J., Windle, H. J., Carton, E., Ravi, N., Kelleher, D., & Reynolds, J. V. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000118751.95179.c6 · Cited by 201
“NF- B also activates expression of several antiapoptotic genes including the cellular inhibitors of apoptosis (c-1AP1, c-1AP2 and 1XAP), the TNF receptor-associated factors (TRAF1 and TRAF2), the Bcl-2 homologue A1/Bfl-1, and 1EX-IL and p53.(25,26) Moreover, overexpression of NF- B or its activation by IL-1 protects a…”
BackgroundLong Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p
Xu, J., Meng, Q., Li, X., Yang, H., Xu, J., Gao, N., Sun, H., Wu, S., Familiari, G., Relucenti, M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3880 · Cited by 196
Han, A., Chien, A. L., & Kang, S. (2014) · Dermatologic Clinics · doi:10.1016/j.det.2014.03.015 · Cited by 194
Yang, L., Francois, F., & Pei, Z. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0934 · Cited by 192
Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis
González-Ramos, R., Van Langendonckt, A., Defrère, S., Lousse, J.-C., Colette, S., Devoto, L., & Donnez, J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.01.013 · Cited by 179
Erratum: NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri968 · Cited by 165
The ubiquitin–proteasome system in cardiovascular diseases—a hypothesis extended
Herrmann, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.033 · Cited by 165
“2, the ubiquitin–proteasome system takes center stage in the main activation pathway of NFnB, which leads to the expression of a number of inflammation-related genes [36–40].”
BackgroundHerbal Processing and Extraction Technologies
Mohammad Azmin, S. N. H., Abdul Manan, Z., Wan Alwi, S. R., Chua, L. S., Mustaffa, A. A., & Yunus, N. A. (2016) · Separation & Purification Reviews · doi:10.1080/15422119.2016.1145395 · Cited by 160
“Flavonoids have been utilized to improve human health via their multiple biological functions including anti-inflammatory (20), antimicrobial (21), antioxidant (22), and anticancer activities (23) and the prevention of osteoporosis (24).”
BackgroundParker, S., May, B., Zhang, C., Zhang, A. L., Lu, C., & Xue, C. C. (2016) · Phytotherapy Research · doi:10.1002/ptr.5653 · Cited by 160
Nuclear Factor-κB1 (p50) Limits the Inflammatory and Fibrogenic Responses to Chronic Injury
Oakley, F., Mann, J., Nailard, S., Smart, D. E., Mungalsingh, N., Constandinou, C., Ali, S., Wilson, S. J., Millward-Sadler, H., Iredale, J. P., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62291-2 · Cited by 123
Saika, S., Miyamoto, T., Yamanaka, O., Kato, T., Ohnishi, Y., Flanders, K. C., Ikeda, K., Nakajima, Y., Kao, W. W.-Y., Sato, M., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62357-7 · Cited by 102
Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury
Kim, S., Lee, S. A., Yoon, H., Kim, M. Y., Yoo, J.-K., Ahn, S.-H., Park, C. H., Park, J., Nam, B. Y., Park, J. T., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.04.039 · Cited by 100
Hseu, Y.-C., Vudhya Gowrisankar, Y., Chen, X.-Z., Yang, Y.-C., & Yang, H.-L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2576823 · Cited by 81
MK-801 and 7-Ni attenuate the activation of brain NF-κB induced by LPS
Glezer, I., Munhoz, C. D., Kawamoto, E. M., Marcourakis, T., Avellar, M. C. W., & Scavone, C. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00279-x · Cited by 79
Electrospun anti-inflammatory patch loaded with essential oils for wound healing
García-Salinas, S., Evangelopoulos, M., Gámez-Herrera, E., Arruebo, M., Irusta, S., Taraballi, F., Mendoza, G., & Tasciotti, E. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119067 · Cited by 79
Rivera, D. G., Hernández, I., Merino, N., Luque, Y., Álvarez, A., Martín, Y., Amador, A., Nuevas, L., & Delgado, R. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01328.x · Cited by 74
Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health
Zulet, M. A., Marti, A., Parra, M. D., & Martínez, J. A. (2005) · Journal of Physiology and Biochemistry · doi:10.1007/bf03168454 · Cited by 62
The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice
Park, J.-R., Lee, H., Kim, S.-I., & Yang, S.-R. (2016) · Oncotarget · doi:10.18632/oncotarget.11168 · Cited by 60
Quercetin’s effect on cycling efficiency and substrate utilization
Dumke, C. L., Nieman, D. C., Utter, A. C., Rigby, M. D., Quindry, J. C., Triplett, N. T., McAnulty, S. R., & McAnulty, L. S. (2009) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h09-099 · Cited by 41
Regulation of NF-Κb Activity in Astrocytes: Effects of Flavonoids at Dietary-Relevant Concentrations
Spilsbury, A., Vauzour, D., Spencer, J. P. E., & Rattray, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.081 · Cited by 32
Alkhoury, H., Hautmann, A., Fuhrmann, B., Syrowatka, F., Erdmann, F., Zhou, G., Stojanović, S., Najman, S., & Groth, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103724 · Cited by 30
Metadata
- Authors
- Yamamoto, Y., & Gaynor, R. B.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-01-15
- Volume
- 107
- Issue
- 2
- Pages
- 135-142
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2086189875
- Cited by
- 1,585
- References
- 48
- FWCI
- 30.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.